Cancer Research Revenue and Competitors

Phoenix, AZ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cancer Research's estimated annual revenue is currently $2.8M per year.(i)
  • Cancer Research's estimated revenue per employee is $155,000

Employee Data

  • Cancer Research has 18 Employees.(i)
  • Cancer Research grew their employee count by -42% last year.

Cancer Research's People

NameTitleEmail/Phone
1
SVP, BioengineeringReveal Email/Phone
2
SVP, Discovery ResearchReveal Email/Phone
3
Director Business Development OperationsReveal Email/Phone
4
CHIEF BUSINESS AND LEGAL OFFICERReveal Email/Phone
5
CHIEF FINANCIAL OFFICERReveal Email/Phone
6
DRUG DEVELOPMENT ADVISORReveal Email/Phone
7
Research Associate IIIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$944.4M27765%N/AN/A
Add Company

What Is Cancer Research?

At Systems Oncology, we believe that innovating cancer drug discovery requires the exponential power of AI to uncover deeper mechanistic insights into cancer biology. Equipped with advanced cognitive computing technologies, we are able to aggregate and mine disparate types of biomedical datasets to reveal novel contextual vulnerabilities in cancer, and collaborate with leading universities to exploit those vulnerabilities with cutting-edge agents. We then invest in the most promising experimental agents to demonstrate their therapeutic potential. Finally, we partner with pharmaceutical companies to transform innovative new agents into the next breakthrough cancer therapies. Our multidisciplinary team includes world-class experts from fields ranging from mathematics and AI to systems biology and oncology, all guided by deep clinical development experience. The combined expertise and our revolutionary approach empower us to discover and develop the next generation of cancer therapies with unprecedented speed and precision.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

-42%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cancer Research News

2022-04-17 - Israeli, South Korean nanodrug precisely attacks chemo-resistant cancer

A single nanoparticle does two jobs: enhancing the effectiveness of chemotherapy and reinvigorating the immune system.

2022-04-17 - Mindblowing' gene discovery brings tailor-made cancer treatment a step closer

Cambridge research reveals 58 new mutational signatures, raising hopes of a cancer care revolution based around personalised treatment.

2022-04-17 - Cancer: Huge DNA analysis uncovers new clues

An "archaeological dig" of thousands of tumours in the UK has unearthed new patterns in cancer's DNA.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M1850%N/A
#2
$2.6M18N/AN/A
#3
$4.5M1820%N/A
#4
$1.6M18-42%N/A
#5
$2.9M18-5%N/A